Stock Taper
SCREENER COMPARE ANY 2 STOCKS
RMTI
ROCKWELL MEDICAL, INC.
NASDAQ
$8.17
▲ UP 5.42% (0.42)

KEY STATISTICS

Market Cap$32.25 M
52w High$19.10
52w Low$4.89
Dividend Yield—
Frequency—
P/E-6.10
Volume36.44K
Shares Out.3.95M

COMPANY

LEADERSHIP

Mark Strobeck
CHIEF EXECUTIVE
Mark Strobeck

COMPENSATION 2026

Salary$566,500
Stock Awards$612,040
Incentive Plan Pay$453,200
All Other Comp.$14,000
Total$1,895,472

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 27, 1998
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
157

PRICE TARGET

Target High$20.00
Target Low$20.00
Target Median$20.00
Target Consensus$20.00

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$18.27M
NOV
11
WED

SPLIT RECORD

DATETYPERATIO
2026-07-01Reverse1:10
2022-05-13Reverse1:11

PRICE

$8.17 ▲ UP 5.42% (+$0.42)
OVERLAYS
$7.80$8.00$8.209:33 AM10:37 AM11:42 AM12:46 PM1:50 PM2:55 PM3:59 PM8.17

About Rockwell Medical, Inc.

https://www.rockwellmed.com ↗

Rockwell Medical, Inc. develops therapies and products for end-stage renal and chronic kidney disease, including iron therapies and dialysis concentrates, serving dialysis centers and developing treatments for acute heart failure and home infusion.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT ROCKWELL MEDICAL, INC. IS KNOWN FOR

RenalPure® and SteriLyte® Hemodialysis Concentrates Convenience Pack
RenalPure® and SteriLyte® Hemodialysis Concentrates Convenience Pack

Rockwell Medical's new RenalPure® and SteriLyte® packaging focus on concentrates for at-home and acute dialysis, highlighted by a September 2024 US provider agreement, emphasizing their growth in the dialysis concentrates market.

COMPETITORS

COMPETITOR
ABT COMPARE
BAX COMPARE
DVA COMPARE
FMS COMPARE
MDT COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q3-2025Q4-2025Q1-2026
Reportable Segment— — — $17.34M
Concentrate Products$16.07M $15.93M ▼$0 ▼—

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$13.82M $15.91M ▲$14.56M ▼$15.13M ▲
NonUS$2.1M $2.44M ▲$2.77M ▲$2.65M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
10
LISTED HERE
1
RANKED BY POSITION SIZE
VTS.AX
0.00% · 84.5K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
56
TOP 12 OF 56 · RANKED BY POSITION SIZE
Armistice Capital, LLC
2.1M sh · $1.82M
Vanguard Group Inc
1.4M sh · $1.17M
Renaissance Technologies LLC
639.1K sh · $570.86K
Geode Capital Management, LLC
429.2K sh · $383.42K
Blackrock, Inc.
236.7K sh · $211.4K
Blackrock Inc.
218.7K sh · $384.95K
Ubs Group AG
178.9K sh · $159.75K
Gsa Capital Partners Llp
164.0K sh · $197K
Wealthspire Advisors, LLC
151.8K sh · $135.62K
Northern Trust Corp
104.5K sh · $93.36K
Jane Street Group, LLC
101.1K sh · $84.25K
State Street Corp
100.9K sh · $90.13K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
DIRECTOR
Dawson Joseph H
Purchase · 9.6K shares
2026-07-01
★
DIRECTOR
Nissenson Allen
Purchase · 9.6K shares
2026-07-01
★
DIRECTOR
Lau Joan
Purchase · 9.6K shares
2026-07-01
★
DIRECTOR
Radie Robert S
Purchase · 9.6K shares
2026-07-01

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
CPIX$8.46COMPARE
ATHE$4.51COMPARE
TLPH$1.20COMPARE
STRR$10.31COMPARE
QNTM$3.08COMPARE
EVAX$3.01COMPARE
NMTC$1.77COMPARE
LIMN$4.23COMPARE